- Home
- NKLR vs INBX Comparison
NKLR vs INBX Comparison
Compare NKLR & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKLR
- INBX
- Stock Information
- Founded
- NKLR 2018
- INBX 2010
- Country
- NKLR Italy
- INBX United States
- Employees
- NKLR N/A
- INBX N/A
- Industry
- NKLR Metal Fabrications
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- NKLR Industrials
- INBX Health Care
- Exchange
- NKLR Nasdaq
- INBX Nasdaq
- Market Cap
- NKLR 398.3M
- INBX 430.2M
- IPO Year
- NKLR N/A
- INBX 2020
- Fundamental
- Price
- NKLR $4.47
- INBX $79.16
- Analyst Decision
- NKLR
- INBX Hold
- Analyst Count
- NKLR 0
- INBX 2
- Target Price
- NKLR N/A
- INBX N/A
- AVG Volume (30 Days)
- NKLR 1.8M
- INBX 790.6K
- Earning Date
- NKLR 01-01-0001
- INBX 11-14-2025
- Dividend Yield
- NKLR N/A
- INBX N/A
- EPS Growth
- NKLR N/A
- INBX N/A
- EPS
- NKLR N/A
- INBX N/A
- Revenue
- NKLR N/A
- INBX $1,400,000.00
- Revenue This Year
- NKLR N/A
- INBX $563.00
- Revenue Next Year
- NKLR N/A
- INBX $230.77
- P/E Ratio
- NKLR N/A
- INBX N/A
- Revenue Growth
- NKLR N/A
- INBX N/A
- 52 Week Low
- NKLR $4.31
- INBX $10.81
- 52 Week High
- NKLR $21.91
- INBX $86.64
- Technical
- Relative Strength Index (RSI)
- NKLR N/A
- INBX 72.20
- Support Level
- NKLR N/A
- INBX $72.00
- Resistance Level
- NKLR N/A
- INBX $83.76
- Average True Range (ATR)
- NKLR 0.00
- INBX 7.89
- MACD
- NKLR 0.00
- INBX -0.86
- Stochastic Oscillator
- NKLR 0.00
- INBX 75.33
About NKLR Terra Innovatum Global N.V. Ordinary shares
Terra Innovatum Global NV is a micro modular nuclear solutions company that aims to deliver reliable, low-cost and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor SOLO. SOLO is compact yet extremely powerful with one unit generating 1MWe of power, while designed with the strictest safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE). SOLO is built using off-the-shelf components and widely available fuel, low-enriched uranium (LEU), which de-risks its regulatory and commercial pathway.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.